XML 48 R24.htm IDEA: XBRL DOCUMENT v3.20.1
NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2020
Accounting Policies [Abstract]  
The following table provides information about disaggregated revenue by product mix

The following table provides information about disaggregated revenue by product mix for the three months ended March 31, 2020 and 2019:

 

   Three Months Ended
March 31,
   2020  2019
Prescription vitamins  $2,473,691   $1,935,971 
IMVEXXY   6,392,601    2,010,680 
BIJUVA   1,111,604    —   
ANNOVERA   2,272,761    —   
     Net revenue  $12,250,657   $3,946,651